HECW1
geneOn this page
Also known as KIAA0322NEDL1
Summary
HECW1 (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1, HGNC:22195) is a protein-coding gene on chromosome 7p14.1-p13, encoding E3 ubiquitin-protein ligase HECW1 (Q76N89). E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1.
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in regulation of dendrite morphogenesis and ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.
Source: NCBI Gene 23072 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 232 total
- MANE Select transcript:
NM_015052
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22195 |
| Approved symbol | HECW1 |
| Name | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
| Location | 7p14.1-p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA0322, NEDL1 |
| Ensembl gene | ENSG00000002746 |
| Ensembl biotype | protein_coding |
| OMIM | 610384 |
| Entrez | 23072 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 8 protein_coding_CDS_not_defined, 4 protein_coding
ENST00000395891, ENST00000429529, ENST00000453890, ENST00000461842, ENST00000464944, ENST00000471043, ENST00000471527, ENST00000481031, ENST00000490954, ENST00000492310, ENST00000493057, ENST00000857209
RefSeq mRNA: 2 — MANE Select: NM_015052
NM_001287059, NM_015052
CCDS: CCDS5469, CCDS69286
Canonical transcript exons
ENST00000395891 — 30 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001488227 | 43112647 | 43112937 |
| ENSE00001593234 | 43552222 | 43552336 |
| ENSE00001597880 | 43450828 | 43450929 |
| ENSE00001606426 | 43554592 | 43554790 |
| ENSE00001625018 | 43456297 | 43456447 |
| ENSE00001635942 | 43508969 | 43509121 |
| ENSE00001644198 | 43541163 | 43541261 |
| ENSE00001644279 | 43541869 | 43541998 |
| ENSE00001673445 | 43561815 | 43566001 |
| ENSE00001678628 | 43463660 | 43463799 |
| ENSE00001679485 | 43500699 | 43500782 |
| ENSE00001706825 | 43493084 | 43493180 |
| ENSE00001707285 | 43550445 | 43550591 |
| ENSE00001708899 | 43243875 | 43243932 |
| ENSE00001726462 | 43508018 | 43508131 |
| ENSE00001732068 | 43479610 | 43479744 |
| ENSE00001740935 | 43468920 | 43469105 |
| ENSE00001750269 | 43444218 | 43445570 |
| ENSE00001750459 | 43507137 | 43507257 |
| ENSE00001758607 | 43501213 | 43501322 |
| ENSE00001759332 | 43492075 | 43492180 |
| ENSE00001766960 | 43466447 | 43466568 |
| ENSE00001773457 | 43442529 | 43442629 |
| ENSE00002265501 | 43438003 | 43438145 |
| ENSE00002268386 | 43114157 | 43114391 |
| ENSE00003488009 | 43407562 | 43407731 |
| ENSE00003521980 | 43360886 | 43360980 |
| ENSE00003598940 | 43396814 | 43396889 |
| ENSE00003671326 | 43311763 | 43312087 |
| ENSE00003677574 | 43320635 | 43320742 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 93.73.
FANTOM5 (CAGE): breadth broad, TPM avg 3.6338 / max 150.4080, expressed in 509 samples.
FANTOM5 promoters (15 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78339 | 1.5132 | 216 |
| 78351 | 0.4565 | 203 |
| 78338 | 0.3210 | 89 |
| 78346 | 0.3179 | 67 |
| 78352 | 0.2937 | 153 |
| 78336 | 0.2370 | 87 |
| 78347 | 0.0991 | 39 |
| 78342 | 0.0837 | 52 |
| 78344 | 0.0706 | 33 |
| 78337 | 0.0617 | 34 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 23 | UBERON:0013554 | 93.73 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 93.19 | gold quality |
| endothelial cell | CL:0000115 | 91.83 | gold quality |
| primary visual cortex | UBERON:0002436 | 87.31 | gold quality |
| cortical plate | UBERON:0005343 | 86.00 | gold quality |
| occipital lobe | UBERON:0002021 | 84.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.89 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.83 | gold quality |
| frontal cortex | UBERON:0001870 | 80.06 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.81 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 79.51 | gold quality |
| pons | UBERON:0000988 | 79.46 | gold quality |
| neocortex | UBERON:0001950 | 79.39 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 78.87 | gold quality |
| right frontal lobe | UBERON:0002810 | 78.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 78.39 | gold quality |
| parietal lobe | UBERON:0001872 | 77.91 | gold quality |
| postcentral gyrus | UBERON:0002581 | 77.29 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.99 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 76.89 | silver quality |
| entorhinal cortex | UBERON:0002728 | 75.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.39 | gold quality |
| cingulate cortex | UBERON:0003027 | 74.98 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 74.81 | gold quality |
| pancreatic ductal cell | CL:0002079 | 74.58 | silver quality |
| buccal mucosa cell | CL:0002336 | 73.71 | silver quality |
| ventricular zone | UBERON:0003053 | 73.61 | gold quality |
| embryo | UBERON:0000922 | 73.53 | gold quality |
| calcaneal tendon | UBERON:0003701 | 73.31 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-25 | yes | 89.93 |
| E-HCAD-35 | yes | 69.59 |
| E-ANND-3 | yes | 7.36 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
102 targeting HECW1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-5002-5P | 99.76 | 70.84 | 1763 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
Literature-anchored findings (GeneRIF, showing 12)
- interaction among misfolded SOD1, NEDL1, translocon-associated protein-delta, and Dishevelled-1 forms a ubiquitinated protein complex that is included in potentially cytotoxic protein aggregates (PMID:14684739)
- functional interaction of NEDL1 with p53 might contribute to the induction of apoptosis in cancerous cells bearing wild-type p53. (PMID:18223681)
- These findings suggest that the human NEDL1 transgenic mice might develop Amyotrophic lateral sclerosis-like symptoms, showing signs of motor abnormalities, accompanied with significant reduction in muscle strength. (PMID:20976258)
- These findings suggest that RNF43 is associated with p53-mediated apoptosis in collaboration with NEDL1 in colorectal carcinogenesis. (PMID:21108931)
- Ndel1 regulates Dyn2 GTPase activity and impacts GluR1-containing membranes distribution in a manner reminiscent of Dyn2. (PMID:21283621)
- Ndel1 acts as a novel upstream regulator of the trichoplein-Aurora A pathway to inhibit primary cilia assembly. (PMID:26880200)
- The ubiquitin E3 ligase HECW1 catalyzes TTF1 ubiquitination. (PMID:30849519)
- Study reported for the first time that HECW1 mRNA levels were negatively correlated with Gd-IgA1 levels and pointed to a new regulatory mechanism of IgA nephropathy that can explain the aberrant glycosylation of IgA1. (PMID:31057023)
- E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4. (PMID:33529121)
- Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma. (PMID:34348693)
- Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1. (PMID:36674783)
- HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350. (PMID:38049396)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | hecw1b | ENSDARG00000004291 |
| danio_rerio | HECW1 | ENSDARG00000100958 |
| mus_musculus | Hecw1 | ENSMUSG00000021301 |
| rattus_norvegicus | Hecw1 | ENSRNOG00000016046 |
Paralogs (24): UBE3C (ENSG00000009335), NEDD4L (ENSG00000049759), NEDD4 (ENSG00000069869), ITCH (ENSG00000078747), HACE1 (ENSG00000085382), HUWE1 (ENSG00000086758), HECTD1 (ENSG00000092148), UBR5 (ENSG00000104517), SMURF2 (ENSG00000108854), UBE3A (ENSG00000114062), AREL1 (ENSG00000119682), WWP1 (ENSG00000123124), HERC2 (ENSG00000128731), HECW2 (ENSG00000138411), HERC3 (ENSG00000138641), HERC6 (ENSG00000138642), HERC5 (ENSG00000138646), HERC4 (ENSG00000148634), UBE3B (ENSG00000151148), TRIP12 (ENSG00000153827), HECTD2 (ENSG00000165338), HECTD4 (ENSG00000173064), WWP2 (ENSG00000198373), SMURF1 (ENSG00000198742)
Protein
Protein identifiers
E3 ubiquitin-protein ligase HECW1 — Q76N89 (reviewed: Q76N89)
Alternative names: HECT, C2 and WW domain-containing protein 1, HECT-type E3 ubiquitin transferase HECW1, NEDD4-like E3 ubiquitin-protein ligase 1
All UniProt accessions (2): Q76N89, H7C3Q2
UniProt curated annotations — full annotation on UniProt →
Function. E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1. Also targets the mutant SOD1 protein involved in familial amyotrophic lateral sclerosis (FALS). Forms cytotoxic aggregates with DVL1, SSR3 and mutant SOD1 that lead to motor neuron death in FALS.
Subunit / interactions. Interacts with DVL1 and SSR3. Also interacts with mutant SOD1.
Subcellular location. Cytoplasm.
Tissue specificity. Predominantly expressed in neurons of adult and fetal brain. Weakly expressed in the kidney.
Pathway. Protein modification; protein ubiquitination.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q76N89-1 | 1 | yes |
| Q76N89-2 | 2 |
RefSeq proteins (2): NP_001273988, NP_055867* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000008 | C2_dom | Domain |
| IPR000569 | HECT_dom | Domain |
| IPR001202 | WW_dom | Domain |
| IPR032348 | HECW_N | Domain |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR035983 | Hect_E3_ubiquitin_ligase | Homologous_superfamily |
| IPR036020 | WW_dom_sf | Homologous_superfamily |
| IPR037795 | C2_HECW | Domain |
| IPR040524 | HECW1_helix | Domain |
| IPR050409 | E3_ubiq-protein_ligase | Family |
Pfam: PF00168, PF00397, PF00632, PF16562, PF18436
Enzyme classification (BRENDA):
- EC 2.3.2.26 — HECT-type E3 ubiquitin transferase (BRENDA: 14 organisms, 64 substrates, 19 inhibitors, 5 Km, 5 kcat entries)
Substrate kinetics (BRENDA)
1 substrates with measured Km, best-characterized 1. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| [UBC5B]-L-LYSINE | 0.0046–0.037 | 5 |
UniProt features (36 total): compositionally biased region 9, helix 6, region of interest 5, domain 4, modified residue 3, strand 3, chain 1, coiled-coil region 1, active site 1, splice variant 1, sequence conflict 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3L4H | X-RAY DIFFRACTION | 1.8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q76N89-F1 | 61.55 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 1574 (glycyl thioester intermediate)
Post-translational modifications (3): 874, 937, 939
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-4641258 | Degradation of DVL |
MSigDB gene sets: 118 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_DENDRITE_DEVELOPMENT, TGGTGCT_MIR29A_MIR29B_MIR29C, ATACCTC_MIR202, GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_DENDRITE_MORPHOGENESIS, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT, GOBP_CELL_PROJECTION_ORGANIZATION
GO Biological Process (4): ubiquitin-dependent protein catabolic process (GO:0006511), protein ubiquitination (GO:0016567), regulation of dendrite morphogenesis (GO:0048814), negative regulation of canonical Wnt signaling pathway (GO:0090090)
GO Molecular Function (4): ubiquitin protein ligase activity (GO:0061630), ubiquitin-protein transferase activity (GO:0004842), protein binding (GO:0005515), transferase activity (GO:0016740)
GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| TCF dependent signaling in response to WNT | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| protein ubiquitination | 1 |
| modification-dependent protein catabolic process | 1 |
| protein modification by small protein conjugation | 1 |
| regulation of anatomical structure morphogenesis | 1 |
| dendrite morphogenesis | 1 |
| regulation of dendrite development | 1 |
| negative regulation of Wnt signaling pathway | 1 |
| canonical Wnt signaling pathway | 1 |
| regulation of canonical Wnt signaling pathway | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| ubiquitin-like protein transferase activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1430 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HECW1 | SSR4 | P51571 | 887 |
| HECW1 | NDFIP1 | Q9BT67 | 823 |
| HECW1 | DVL1 | O14640 | 791 |
| HECW1 | SOD1 | P00441 | 747 |
| HECW1 | UBE2K | P27924 | 598 |
| HECW1 | RNF43 | Q68DV7 | 585 |
| HECW1 | UBE2S | Q16763 | 564 |
| HECW1 | NEDD8 | Q15843 | 554 |
| HECW1 | PTEN | P60484 | 506 |
| HECW1 | A0A087WY85 | A0A087WY85 | 479 |
| HECW1 | RHOBTB3 | O94955 | 446 |
| HECW1 | WNT1 | P04628 | 445 |
| HECW1 | AGBL3 | Q8NEM8 | 432 |
| HECW1 | ST8SIA1 | Q92185 | 428 |
| HECW1 | ZC3H12C | Q9C0D7 | 427 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARRDC3 | WWP2 | psi-mi:“MI:0914”(association) | 0.770 |
| LDLRAD4 | NEDD4 | psi-mi:“MI:0914”(association) | 0.690 |
| VAX1 | HECW1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LDLRAD4 | WWP2 | psi-mi:“MI:0914”(association) | 0.530 |
| ENTREP3 | NEDD4 | psi-mi:“MI:0914”(association) | 0.530 |
| PRRG4 | HECW1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| HECW1 | FBXL15 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HECW1 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| HECW1 | SHANK3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HECW1 | TSC1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CACNA1A | HECW1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MPHOSPH8 | HCFC1 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM189B | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| LDLRAD4 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM171 | STX6 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF707 | LRP4 | psi-mi:“MI:0914”(association) | 0.350 |
| ILDR1 | FBP1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRRG1 | GGCX | psi-mi:“MI:0914”(association) | 0.350 |
| CUEDC1 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| DLG3 | KIF1B | psi-mi:“MI:0914”(association) | 0.350 |
| ENTREP3 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| HECW1 | VAX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GFI1B | HECW1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| USP7 | HECW1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (44): HECW1 (Affinity Capture-MS), HECW1 (Affinity Capture-MS), UBC (Biochemical Activity), UBE2D1 (Reconstituted Complex), UBE2D2 (Reconstituted Complex), UBE2D3 (Reconstituted Complex), UBE2L3 (Reconstituted Complex), HECW1 (Biochemical Activity), UBE2J2 (Reconstituted Complex), DVL1 (Two-hybrid), HECW1 (Affinity Capture-MS), HECW1 (Affinity Capture-MS), HECW1 (PCA), HECW1 (Affinity Capture-Western), HECW1 (Affinity Capture-Western)
ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9
Diamond homologs: A0A8C0NGY6, A1CQG2, A1D3C5, A2A5Z6, A2QQ28, A9JRZ0, B0XQ72, B8N7E5, D3ZBM7, D6C652, E1B7Q7, E1C656, F1LP64, F1N6G5, F8W2M1, G0S9J5, G5E870, H2LBU8, O00308, O08759, O13834, O14326, O15033, P39940, P40985, P46934, P46935, P46937, P46938, P51593, P53119, Q03280, Q05086, Q08CZ0, Q09291, Q0CCL1, Q14669, Q15034, Q15386, Q1K9C4
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | HECW1 | ubiquitination |
| HECW1 | “down-regulates quantity by destabilization” | DVL1 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
232 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 198 |
| Likely benign | 3 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
8285 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:43138287:GCT:G | donor_gain | 1.0000 |
| 7:43219518:G:GG | donor_gain | 1.0000 |
| 7:43312048:G:GT | donor_gain | 1.0000 |
| 7:43312085:TTG:T | donor_gain | 1.0000 |
| 7:43312085:TTGG:T | donor_loss | 1.0000 |
| 7:43312086:TGG:T | donor_loss | 1.0000 |
| 7:43312088:GTG:G | donor_loss | 1.0000 |
| 7:43312089:T:G | donor_loss | 1.0000 |
| 7:43312090:GAG:G | donor_loss | 1.0000 |
| 7:43320611:T:TA | acceptor_gain | 1.0000 |
| 7:43320624:T:TA | acceptor_gain | 1.0000 |
| 7:43320625:G:A | acceptor_gain | 1.0000 |
| 7:43320632:T:G | acceptor_gain | 1.0000 |
| 7:43320632:TA:T | acceptor_loss | 1.0000 |
| 7:43320633:A:AG | acceptor_gain | 1.0000 |
| 7:43320633:AGAT:A | acceptor_gain | 1.0000 |
| 7:43320634:G:GA | acceptor_gain | 1.0000 |
| 7:43320634:GA:G | acceptor_gain | 1.0000 |
| 7:43320634:GAT:G | acceptor_gain | 1.0000 |
| 7:43320634:GATG:G | acceptor_gain | 1.0000 |
| 7:43320634:GATGA:G | acceptor_gain | 1.0000 |
| 7:43320738:GGAAC:G | donor_gain | 1.0000 |
| 7:43320739:GAAC:G | donor_gain | 1.0000 |
| 7:43320739:GAACG:G | donor_gain | 1.0000 |
| 7:43320740:A:T | donor_gain | 1.0000 |
| 7:43320740:AAC:A | donor_gain | 1.0000 |
| 7:43320741:AC:A | donor_gain | 1.0000 |
| 7:43320741:ACG:A | donor_loss | 1.0000 |
| 7:43320742:CGT:C | donor_loss | 1.0000 |
| 7:43320743:G:GG | donor_gain | 1.0000 |
AlphaMissense
10572 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:43311977:T:A | L81H | 1.000 |
| 7:43311977:T:C | L81P | 1.000 |
| 7:43312033:T:A | W100R | 1.000 |
| 7:43312033:T:C | W100R | 1.000 |
| 7:43312034:G:C | W100S | 1.000 |
| 7:43312035:G:C | W100C | 1.000 |
| 7:43312035:G:T | W100C | 1.000 |
| 7:43312040:T:A | I102K | 1.000 |
| 7:43312063:G:C | D110H | 1.000 |
| 7:43312064:A:C | D110A | 1.000 |
| 7:43312064:A:T | D110V | 1.000 |
| 7:43312066:T:A | W111R | 1.000 |
| 7:43312066:T:C | W111R | 1.000 |
| 7:43312070:T:A | I112N | 1.000 |
| 7:43312072:G:C | G113R | 1.000 |
| 7:43312073:G:A | G113D | 1.000 |
| 7:43312078:T:G | Y115D | 1.000 |
| 7:43320673:C:A | R131S | 1.000 |
| 7:43320709:T:A | W143R | 1.000 |
| 7:43320709:T:C | W143R | 1.000 |
| 7:43360904:T:C | F160S | 1.000 |
| 7:43360909:T:C | Y162H | 1.000 |
| 7:43360909:T:G | Y162D | 1.000 |
| 7:43360912:T:G | Y163D | 1.000 |
| 7:43360939:G:C | A172P | 1.000 |
| 7:43360961:T:A | V179D | 1.000 |
| 7:43407580:T:C | L217S | 1.000 |
| 7:43407580:T:G | L217W | 1.000 |
| 7:43407588:G:A | G220R | 1.000 |
| 7:43407588:G:C | G220R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000005560 (7:43328138 T>C), RS1000007825 (7:43269349 G>T), RS1000015538 (7:43417401 A>C,G,T), RS1000023021 (7:43183963 A>T), RS1000027188 (7:43143091 C>T), RS1000027717 (7:43446550 G>A), RS1000033341 (7:43278192 A>G), RS1000048260 (7:43417625 G>A), RS1000049934 (7:43196752 G>A), RS1000058465 (7:43187913 G>A,C), RS1000059528 (7:43114033 T>G), RS1000060676 (7:43547105 C>T), RS1000065344 (7:43221565 T>C,G), RS1000082319 (7:43306480 C>A,T), RS1000084550 (7:43523994 A>G)
Disease associations
OMIM: gene MIM:610384 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_407 | Obesity-related traits | 6.000000e-06 |
| GCST001915_44 | Alzheimer’s disease (cognitive decline) | 1.000000e-06 |
| GCST002560_4 | Type 2 diabetes | 4.000000e-06 |
| GCST002927_9 | Mercury levels | 7.000000e-06 |
| GCST003072_4 | Cerebrospinal fluid AB1-42 levels | 3.000000e-07 |
| GCST003654_12 | Bone mineral density (Ward’s triangle area) | 5.000000e-06 |
| GCST004159_4 | Serum galactose-deficient IgA1 levels | 6.000000e-06 |
| GCST004749_18 | Lung cancer in ever smokers | 7.000000e-06 |
| GCST005851_27 | Delirium | 5.000000e-06 |
| GCST006535_5 | Irritable bowel syndrome | 4.000000e-06 |
| GCST008257_4 | Diverticular disease | 1.000000e-06 |
| GCST009175_8 | Caudal anterior-cingulate cortex volume | 3.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003939 | energy intake |
| EFO:0004670 | beta-amyloid 1-42 measurement |
| EFO:0007785 | femoral neck bone mineral density |
| EFO:0009959 | diverticular disease |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10255565 | HECW1 | 0.00 | 0 |
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases mutagenesis | 3 |
| bisphenol A | decreases methylation, increases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | decreases expression | 1 |
| Bortezomib | increases expression, increases response to substance | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): delirium, irritable bowel syndrome